Search Results 371-380 of 16976 for monoclonal antibody
... antibodies predict a worse prognosis. ... Bahn says: "We treated GO fibroblasts with a high-affinity human stimulatory monoclonal antibody directed against TSH ...
About this study ... Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as ...
The extraordinary mutation of the Omicron variant has caused us to lose two sets of monoclonal antibodies, leaving us with one monoclonal antibody for ...
Staining with a monoclonal antibody was performed. All study participants had sufficient submandibular gland tissue on at least one side; 12 of the 14 ...
The U.S. Food and Drug Administration (FDA) has approved the use of the human monoclonal antibody bezlotoxumab to reduce the risk of recurrence of C.
... monoclonal antibody therapies, and testing need further investigation. ... Multiple reports found that vaccine-induced antibodies could not bind to or neutralize ...
The purpose of this study is to determine whether monoclonal B-cell lymphocytosis (MBL) has an impact on clinical outcomes among patients with a diagnosis of a ...
Monoclonal antibody. Basiliximab (Simulect) is an immunosuppressant that may be given during the first few days after surgery to prevent rejection ...
RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.